Rani Therapeutics Holdings, Inc. (RANI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 89.29M |
| Enterprise Value | 74.99M |
| P/E Ratio | -1.89 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 15.93 |
| Price/Book Ratio | 4.9 |
| Enterprise/Revenue | 14.13 |
| Enterprise/EBITDA | -1.34 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -9.29 |
| Operating Margin | -10.93 |
AD
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | -2.45 |
Income Statement
| Revenue | 1.63M |
| Revenue/Share | 0.02 |
| Gross Profit | 733,000 |
| EBITDA | -37.16M |
| Net Income | -29.67M |
| Diluted EPS | -0.45 |
Balance Sheet
| Total Cash | 43.4M |
| Total Cash/Share | 0.24 |
| Total Debt | 3.94M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 3.4 |
| Book Value Per Share | 0.2 |
Price History
| 52-Week Change | 57.69 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.39 |
| Moving Average 50 Days | 0.91 |
| Moving Average 200 Days | 1.17 |
Statistics
| Average Volume | 1.1M |
| Shares Outstanding | 65.32M |
| % Held by Institutions | 29.04 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
